Baseline Characteristics of Participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study

American Journal of Kidney Diseases

Volumn 50, Issue 1, 2007, Pages

  Sika, Mohammed ^a   Lewis, Julia ^a   Douglas, Janice ^b   Erlinger, Thomas ^c   Dowie, Donna ^d   Lipkowitz, Michael ^e   Lash, James ^f   Cornish Zirker, Denise ^g   Peterson, Gail ^h   Toto, Robert ^h   Kusek, John ⁱ   Appel, Lawrence ^j   Kendrick, Cynthia ^k   Gassman, Jennifer ^k  

^a VANDERBILT UNIVERSITY   (United States)

^b Hypertension Molecular and Applied Physiology Laboratory   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d HARLEM HOSPITAL CENTER   (United States)

^e Mount Sinai University   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^j JOHNS HOPKINS UNIVERSITY   (United States)

^k LERNER RESEARCH INSTITUTE   (United States)

more..

Author keywords

African Americans; baseline; hypertension; kidney disease

Indexed keywords

ALBUMIN; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IOTALAMIC ACID; METOPROLOL; PROTEIN; RAMIPRIL;

ADULT; AFRICAN AMERICAN; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE REGULATION; CAUSE OF DEATH; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 34250759711     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.03.004     Document Type: Article

References (23)

1. US Renal Data System: USRDS 2006 Annual Data Report (2006), The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
2. Gassman J.J., Greene T., Wright J.T., et al. Design and statistical aspects of the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol 14 (2003) 5154-5165
3. Wright J.T., Kusek T.W., Toto R.D., et al. Design and baseline characteristics of participation in the African American Study of Kidney Disease and Hypertension. Control Clin Trials 16 (1996) 35-165
4. Agodoa L.Y., Bakris G.L., Beck G., et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis. JAMA 285 (2001) 2719-2728
5. Wright J.T., Bakris G., Greene T., et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. JAMA 288 (2002) 2421-2431
6. Appel L.J., Middleton J., Miller E.R., et al. The rationale and design of the AASK Cohort Study. J Am Soc Nephrol 14 suppl 2 (2003) S166-S172
7. Chobanian A.V., Bakris G.L., Black G.L., et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
8. Lewis J., Agodoa L., Cheek D., et al. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis 388 (2001) 744-753
9. Lewis J., Greene T., Appel L., et al. A comparison of iothalamate-GFR and serum creatinine-based outcomes: Acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol 15 (2004) 3175-3183
10. Greene T., Bourgoignie J., Habwe V., et al. Baseline characteristics in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol 3 (1993) 1819-1834
11. Grimm R.H., Margolis K.L., Papademetriou V., et al. Baseline characteristics of participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 37 (2001) 19-27
12. Appel L.J., Hebert P.R., Cohen J.D., et al. Baseline characteristics of participants in phase II of the trials of hypertensive prevention. Ann Epidemol 5 (1995) 149-155
13. Norris K., Greene T., Kopple J., et al. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol 17 (2006) 2928-2936
14. Kafetz K. Renal impairment in the elderly: A review. J Royal Soc Med 76 (1983) 398-401
15. Lindeman R.D., Tobin J., and Shock N.W. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33 (1985) 278-285
16. Hemmelgarn B.R., Zhang J., Manns B.J., et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69 (2006) 2155-2161
17. Salahudeen A.K. Halting progression of renal failure: Consideration beyond angiotensin II inhibition. Nephrol Dial Transplant 17 (2002) 1871-1875
18. Lewis E.J., Hunsiker L.G., Bain R.P., and Rohde R.D. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329 (1993) 1456-1462
19. Lewis E.J., Hunsicker L.G., Clarke W.R., et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345 (2001) 851-860
20. Brenner B.M., Cooper M.E., Zeeuw D.D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345 (2006) 861-869
21. Parving H.H., Lehnert H., Brochner-Mortensen J., et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345 (2001) 870-878
22. The GISEN Group. Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349 (1997) 1857-1963
23. Collins A., Kasiske B., Herzog C., et al. Excerpts from the United States Renal Data System 2004 Annual Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis 45 (2005) v-vii